OBJECTIVE: To determine whether lactoferrin can modify articular inflammation in murine models of autoimmune and septic arthritis. METHODS: Collagen arthritis was induced in DBA/1 mice and Staphylococcus aureus septic arthritis in Swiss mice. Joints with established inflammation were injected periarticularly with 0.5 mg or 1 mg of human lactoferrin, and arthritis was monitored for 3 days. RESULTS: DBA/1 mice injected with lactoferrin showed significantly suppressed local inflammation for up to 3 days, achieving up to 71% of the effect of corticosteroid. Periarticular injection of 125I-lactoferrin confirmed that 25% of lactoferrin was retained in paws after 6 hours. Serum levels of interleukin-6, however, were not significantly reduced, suggesting a predominantly local antiinflammatory effect. Similarly, local, periarticular administration of lactoferrin into S aureus-infected Swiss mice significantly suppressed paw inflammation and did not enhance bacterial survival. CONCLUSION: Lactoferrin may have clinical utility in reducing articular inflammation, particularly in septic arthritis, in which antiinflammatory effects may be achieved without promoting bacterial survival.
OBJECTIVE: To determine whether lactoferrin can modify articular inflammation in murine models of autoimmune and septic arthritis. METHODS: Collagen arthritis was induced in DBA/1 mice and Staphylococcus aureus septic arthritis in Swiss mice. Joints with established inflammation were injected periarticularly with 0.5 mg or 1 mg of humanlactoferrin, and arthritis was monitored for 3 days. RESULTS:DBA/1 mice injected with lactoferrin showed significantly suppressed local inflammation for up to 3 days, achieving up to 71% of the effect of corticosteroid. Periarticular injection of 125I-lactoferrin confirmed that 25% of lactoferrin was retained in paws after 6 hours. Serum levels of interleukin-6, however, were not significantly reduced, suggesting a predominantly local antiinflammatory effect. Similarly, local, periarticular administration of lactoferrin into S aureus-infected Swiss mice significantly suppressed paw inflammation and did not enhance bacterial survival. CONCLUSION:Lactoferrin may have clinical utility in reducing articular inflammation, particularly in septic arthritis, in which antiinflammatory effects may be achieved without promoting bacterial survival.
Authors: Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im Journal: Gene Date: 2013-07-02 Impact factor: 3.688
Authors: Jae-Sung Kim; Michael B Ellman; Dongyao Yan; Howard S An; Ranjan Kc; Xin Li; Di Chen; Guozhi Xiao; Gabriella Cs-Szabo; David W Hoskin; Doug D Buechter; Andre J Van Wijnen; Hee-Jeong Im Journal: J Cell Physiol Date: 2013-09 Impact factor: 6.384
Authors: Michael B Ellman; Jaesung Kim; Howard S An; Di Chen; Ranjan Kc; Xin Li; Guozhi Xiao; Dongyao Yan; Joon Suh; Andre J van Wijnen; James H-C Wang; Su-Gwan Kim; Hee-Jeong Im Journal: Gene Date: 2013-04-30 Impact factor: 3.688
Authors: S H Wong; N Francis; H Chahal; K Raza; M Salmon; D Scheel-Toellner; J M Lord Journal: Rheumatology (Oxford) Date: 2008-11-23 Impact factor: 7.580